𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of a heparin binding site and the biological activities of the laminin α1 chain carboxy-terminal globular domain

✍ Scribed by Ichiro Yoshida; Ken-Ichiro Tashiro; Akira Monji; Isao Nagata; Yoshihito Hayashi; Yoshio Mitsuyama; Nobutada Tashiro


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
342 KB
Volume
179
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


The carboxy-terminal globular domain (G-domain) of the laminin ␣1 chain has been shown to promote heparin binding, cell adhesion, and neurite outgrowth. In this study, we defined the potential sequences originating from the G-domain of laminin ␣1 chain which possess these functional activities. A series of peptides were synthesized from the G-domain, termed LG peptides (LG-1 to LG-6) and were tested for their various biological activities. In the direct [ 3 H]heparin binding assays, LG-6 (residues 2,335-2,348: KDFLSIELVRGRVK) mediated high levels of [ 3 H]heparin binding, and this peptide also directly promoted cell adhesion and spreading, including B16F10, M2, HT1080, and PC12 cells. The peptide LG-6 also promoted the neurite outgrowth of PC12 cells, mouse granule cells, and chick telencephalic cells. An anti-peptide LG-6 antibody inhibited laminin-1 and peptide LG-6 -mediated cell adhesion and neurite outgrowth. Furthermore, an anti-integrin ␣2 antibody also inhibited the cell adhesion activity. These results suggest that peptide LG-6 plays a functional role as a heparin binding site in the G-domain of the laminin ␣1 chain, and this sequence was thus concluded to play a crucial role in regulating cell adhesion and spreading and neurite outgrowth which is related to integrin ␣2.


📜 SIMILAR VOLUMES


Laminin inhibition of β-amyloid protein
✍ Gerardo M. Castillo; Widia Lukito; Elaine Peskind; Murray Raskind; Daniel A. Kir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

␤-Amyloid protein (A␤) is a major component of neuritic plaques and cerebrovascular amyloid deposits in the brains of patients with Alzheimer's disease (AD). Inhibitors of A␤ fibrillogenesis are currently sought as potential future therapeutics for AD and related disorders. In the present study, the